Core Insights - Eddycon Holdings (09860) reported annual results for the year ending December 31, 2024, with revenue of 2.914 billion RMB and a net profit attributable to shareholders of 47.014 million RMB, translating to earnings per share of 0.07 RMB [1] Group 1: Financial Performance - The company's regular business revenue, excluding COVID-19 related income, grew by 8.2%, driven by strong growth in specialty testing services, which saw an increase of over 18% compared to the same period in 2023 [1] - Revenue from collaborative business initiatives increased by 62% year-on-year, significantly broadening market coverage and enhancing service offerings [1] Group 2: Technological Advancements - The company upgraded its laboratory systems, including the next-generation LIMS, OMS, reporting platform, PIMS, and logistics systems, aiming to enhance operational efficiency and service quality [2] - The application of artificial intelligence (AI) technology has been expanded, with over 8 million images analyzed, improving diagnostic efficiency and accuracy [2] Group 3: Operational Efficiency - The company implemented various cost control measures, achieving a 10% reduction in reagent procurement costs and a 6% reduction in logistics costs compared to 2023 [3] - The company enhanced labor efficiency in laboratory management by 7% year-on-year, optimizing resource allocation and personnel scheduling [3] - The total number of ISO15189 accredited laboratories increased to 23, with the Hangzhou laboratory achieving a leading 320 accredited testing items, ensuring high service quality and market competitiveness [3]